arrow
A

Alessandro Weisz

laboratory of molecular medicine and genomics
H指数:54
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Correction: Suppression of Spry1 reduces HIF1α‑dependent glycolysis and impairs angiogenesis in BRAF‑mutant cutaneous melanoma

更正:Spry1的抑制降低了BRAF突变型皮肤黑色素瘤中HIF1α依赖的糖酵解并损害了血管生成

2026-08-210
OAAI
AKAP2/PKA complex coordinates primary ciliogenesis, ciliary trafficking and Shh signaling

AKAP2/PKA复合物协调原基纤毛发生、纤毛转运和Shh信号通路

2026-07-220
OA
Identification of LncRNAs scaffolding a chromatin-associated gene regulatory complex in breast cancer cells comprising ERα, DOT1L and menin

在包含er α,DOT1L和menin的乳腺癌细胞中鉴定LncRNAs支架与染色质相关的基因调控复合物

2026-01-300
OAAI
Targeted inhibition of ubiquitin signaling reverses metabolic reprogramming and suppresses glioblastoma growth (vol 5, 780, 2022)
2024-10-290
OAAI
Essential gene screening identifies the bromodomain-containing protein BRPF1 as a new actionable target for endocrine therapy-resistant breast cancers

必需基因筛选确定含溴结构域蛋白BRPF1作为内分泌治疗耐药乳腺癌的新的可操作靶点

2024-08-070
OAAI
Antibody dependent cellular cytotoxicity-inducing anti-EGFR antibodies as effective therapeutic option for cutaneous melanoma resistant to BRAF inhibitors
2024-03-060
OAAI
Downregulation of praja2 restrains endocytosis and boosts tyrosine kinase receptors in kidney cancer
2024-02-201
OAAI
Genomic epidemiology of the main SARS-CoV-2 variants in Italy between summer 2020 and winter 2021
2023-11-050
OA